In Vivo and In Vitro Models of Pancreatic Cancer: A Comparative Study
DOI:
https://doi.org/10.22034/LSSJ.2023.1.60Keywords:
Pancreatic ductal adenocarcinoma, in vitro models ,in vivo modelsAbstract
Pancreatic ductal adenocarcinoma (PDAC) is the most common type of pancreatic cancer and has an extremely low 5-year survival rate of less than 10%, making it one of the deadliest solid tumors. To improve our understanding of the genesis and progression of this devastating disease, novel laboratory approaches have been developed. In this review, we provide a comprehensive summary of the current in vitro and in vivo models of PDAC, including established murine and human PDAC cell lines, organoids, and genetically engineered models. In addition, we compare these models and analyze published in vitro and in vivo PDAC models to elucidate the molecular basis of pancreatic carcinogenesis.
Downloads
Published
How to Cite
Issue
Section
License
Publisher's Own License
This work is licensed under the publisher's own license, which allows for sharing and use under specific conditions. Attribution is required; users must give appropriate credit to the original creator. Additionally, this license includes a No Commercial Usage clause, meaning that the work cannot be used for commercial purposes or for profit. Users are encouraged to share and adapt the content non-commercially, provided they adhere to these guidelines. Please ensure that you respect the terms of this license to promote a collaborative and respectful use of the work.